Symbols and abbreviations |
|
xi | |
Contributors |
|
xxix | |
|
1 Intensive and acute cardiovascular care: an introduction |
|
|
1 | (4) |
|
|
|
|
|
|
SECTION I Intensive and acute cardiovascular care |
|
|
|
2 Training and certification in intensive and acute cardiovascular care |
|
|
5 | (6) |
|
|
|
3 Intensive cardiovascular care units: structure, organization, and staffing |
|
|
11 | (14) |
|
|
|
|
25 | (8) |
|
|
|
|
5 Patient safety and clinical governance |
|
|
33 | (10) |
|
|
|
6 Ethical issues in cardiac arrest and acute cardiac care: a European perspective |
|
|
43 | (11) |
|
|
|
7 Quality of care assessment in acute cardiac care |
|
|
54 | (11) |
|
|
|
SECTION II The pre-hospital phase and the emergency department |
|
|
|
8 The emergency medical system |
|
|
65 | (11) |
|
|
|
|
|
9 Out-of-hospital cardiac arrest |
|
|
76 | (12) |
|
|
|
10 Chest pain in the emergency department and the chest pain unit |
|
|
88 | (15) |
|
|
|
|
11 Acute dyspnoea in the emergency department |
|
|
103 | (12) |
|
|
|
|
|
SECTION III Monitoring and investigations in the intensive cardiovascular care unit |
|
|
|
12 Pathophysiology and clinical assessment of the cardiovascular system (including pulmonary artery catheterization) |
|
|
115 | (12) |
|
|
|
|
13 The respiratory system |
|
|
127 | (7) |
|
|
14 Neurological assessment of the acute cardiac care patient |
|
|
134 | (13) |
|
|
|
|
15 Monitoring of the kidneys, liver, and other vital organs |
|
|
147 | (18) |
|
|
|
|
|
|
|
16 Blood gas analysis: acid-base, fluid, and electrolyte disorders |
|
|
165 | (16) |
|
|
|
17 Interpretation and clinical use of chest radiographs |
|
|
181 | (20) |
|
|
|
|
18.1 Echocardiography and thoracic ultrasound |
|
|
201 | (17) |
|
|
|
|
18.2 Echocardiography and thoracic ultrasound |
|
|
218 | (6) |
|
|
|
|
19 Computerized tomography: coronary angiography and cardiac imaging |
|
|
224 | (22) |
|
|
|
|
|
|
|
20 Cardiac magnetic resonance in the intensive and cardiac care unit |
|
|
246 | (21) |
|
|
|
SECTION IV Procedures in the intensive cardiovascular care unit |
|
|
|
21 Non-invasive ventilation |
|
|
267 | (17) |
|
|
|
|
22 Mechanical ventilation |
|
|
284 | (22) |
|
|
|
|
306 | (8) |
|
|
24 Ultrasound-guided vascular access in intensive/acute cardiac care |
|
|
314 | (9) |
|
|
|
323 | (8) |
|
|
|
|
331 | (7) |
|
|
|
|
|
338 | (13) |
|
|
|
|
28 Percutaneous (short-term) mechanical circulatory support |
|
|
351 | (9) |
|
|
|
29 Nutrition support in acute cardiac care |
|
|
360 | (13) |
|
|
|
30 Physiotherapy in critically ill patients |
|
|
373 | (14) |
|
|
|
SECTION V The laboratory in intensive and acute cardiovascular care |
|
|
|
31 The use of biomarkers for acute cardiovascular disease |
|
|
387 | (13) |
|
|
32 Biomarkers in acute coronary syndromes |
|
|
400 | (9) |
|
|
|
|
|
33 Biomarkers in acute heart failure |
|
|
409 | (16) |
|
|
|
|
|
34 Biomarkers of coagulation and thrombosis |
|
|
425 | (9) |
|
|
|
|
35 Biomarkers of renal and hepatic failure |
|
|
434 | (13) |
|
|
|
|
SECTION VI Acute coronary syndromes |
|
|
|
36 Atherosclerosis and thrombosis |
|
|
447 | (16) |
|
|
|
37 The universal definition of myocardial infarction |
|
|
463 | (16) |
|
|
|
|
|
38 ST-segment elevation myocardial infarction |
|
|
479 | (15) |
|
|
|
39 Fibrinolytic, antiplatelet, and anticoagulant drugs in acute coronary syndromes |
|
|
494 | (19) |
|
|
|
|
|
40 Mechanical complications of myocardial infarction |
|
|
513 | (18) |
|
|
|
41 Non-ST-segment elevation acute coronary syndromes |
|
|
531 | (18) |
|
|
|
42 Percutaneous coronary interventions in acute coronary syndromes |
|
|
549 | (16) |
|
|
|
43 Coronary artery bypass graft surgery |
|
|
565 | (20) |
|
|
|
44 Sex considerations in acute coronary syndromes |
|
|
585 | (18) |
|
|
|
|
SECTION VII Acute heart failure (including cardiogenic shock) |
|
|
|
45 Acute heart failure: epidemiology, classification, and pathophysiology |
|
|
603 | (14) |
|
|
|
46 Acute heart failure: early pharmacological therapy |
|
|
617 | (16) |
|
|
|
|
|
47 Low cardiac output states and cardiogenic shock |
|
|
633 | (18) |
|
|
|
48 Non-pharmacological therapy of acute heart failure: when drugs alone are not enough |
|
|
651 | (13) |
|
|
|
|
|
49 Heart failure surgery and transplantation |
|
|
664 | (16) |
|
|
|
|
50 Implanted cardiac support devices |
|
|
680 | (11) |
|
|
|
|
51 Donor organ management |
|
|
691 | (15) |
|
|
|
|
|
52 Palliative care in the intensive cardiovascular care unit |
|
|
706 | (13) |
|
|
|
|
53 Atrial fibrillation and supraventricular arrhythmias |
|
|
719 | (21) |
|
|
|
54 Ventricular tachyarrhythmias |
|
|
740 | (15) |
|
|
|
|
55 Pacemaker and ICDs: troubleshooting |
|
|
755 | (12) |
|
|
|
SECTION IX Specific acute cardiovascular conditions |
|
|
|
56 Myocarditis and pericarditis |
|
|
767 | (11) |
|
|
|
57 Acute valve disease and endocarditis |
|
|
778 | (17) |
|
|
|
|
|
58 Congenital heart disease in adults |
|
|
795 | (10) |
|
|
|
|
|
805 | (15) |
|
|
|
60 Cardiac complications in trauma |
|
|
820 | (10) |
|
|
|
|
61 Cardiac emergencies in pregnancy |
|
|
830 | (9) |
|
|
|
62 Pulmonary hypertension |
|
|
839 | (10) |
|
|
|
|
|
849 | (14) |
|
|
|
|
SECTION X Concomitant acute conditions |
|
|
|
64 Acute respiratory failure and acute respiratory distress syndrome |
|
|
863 | (17) |
|
|
|
|
|
880 | (15) |
|
|
|
|
|
895 | (17) |
|
|
|
|
67 Stress hyperglycaemia and endocrine emergencies |
|
|
912 | (14) |
|
|
|
|
68 Bleeding and haemostasis disorders |
|
|
926 | (12) |
|
|
|
69 Anaemia and transfusion |
|
|
938 | (7) |
|
|
|
|
|
70 Infection, sepsis, and multiorgan dysfunction syndrome |
|
|
945 | (11) |
|
|
71 Pain in the intensive cardiovascular care unit |
|
|
956 | (13) |
|
|
|
72 Delirium in the intensive cardiovascular care unit |
|
|
969 | (10) |
|
|
|
|
73 Special considerations in the immunosuppressed patient |
|
|
979 | (11) |
|
|
|
74 Perioperative cardiac care of the high-risk non-cardiac patient |
|
|
990 | (19) |
|
|
75 Perioperative management of the high-risk surgical patient: cardiac surgery |
|
|
1009 | (16) |
|
|
|
Index |
|
1025 | |